Evan A. Hecker, Ph.D.
Senior Vice President, Head of CMC
Evan A. Hecker, Ph.D. is an experienced, passionate, and resourceful R&D executive specializing in the small pharma/biotechnology sector. He is a trained process chemist, with extensive experience in drug development and manufacturing, from preclinical research through NDA. He earned a Ph.D. in Organic Synthesis from the University of Texas, at Austin and was a postdoctoral fellow at Harvard University before beginning his career at the bench at Cubist Pharmaceuticals. Since then, he has held roles of increasing responsibility and expanded scope at Karyopharm Therapeutics, Spero Therapeutics, and is currently the SVP, Head of CMC at Ikena Oncology
